ロード中...
IMMU-24. IMMUNOTHERAPEUTIC NANOTECHNOLOGY TARGETING IDO1 FOR PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA
BACKGROUND: Research on adult high-grade gliomas has shown a targetable pathway through the inflammation-induced expression of indoleamine 2,3 dioxygenase (IDO1) and its recognized ability to suppress the anti-tumor immune response. Our project delineates the role of indoleamine 2,3 dioxygenase 1 (I...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012849/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.340 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|